Back to News
Market Impact: 0.12
Jasper Therapeutics Appoints Regulatory, Clinical Executives For Pipeline Development; Stock Up
Source: Nasdaq
Healthcare & BiotechManagement & Governance
Jasper Therapeutics appointed Lisa Pitt as Senior Vice President of Regulatory Affairs and Shiguang Liu as Vice President of Clinical Development. The leadership additions bolster regulatory and clinical-development capabilities at the clinical-stage immune-mediated disease biotech, but no trial, financial, or guidance update was disclosed.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.15
Ticker Sentiment
JSPR0.25
More News
- Jasper Therapeutics at H.C. Wainwright: cash and catalysts
- Analysis: How Trump could reignite the Fed independence fight after Warsh's rate hike
- Snap tries to make the case again for its $2,200 smart glasses
- Premarket movers: Intel jumps on SK Hynix memory-chip talks, J.B. Hunt slides
- Japan has a problematic age gap: 100,000-plus residents are over 100 and the pension system is buckling
- The MLB and its Dominican pipeline is selling false promises and shady contracts to children as young as 11